Extracellular Matrix Deposition via Macromolecular Crowding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro extracellular matrices (ECMs) have unstable bioactivity due to insufficient ECM deposition under standard culture conditions, which is further reduced after decellularization, limiting their effectiveness in inducing terminal differentiation and promoting tissue repair.
Innovation Solution
The use of macromolecular crowding (MMC) and glycosaminoglycans or carbohydrate-based hydrophilic macromolecules, such as hyaluronic acid and Ficoll, to enhance ECM deposition and alter the phenotype of ECM-producing cells, resulting in ECMs with customized anti-inflammatory and pro-angiogenic properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If standard culture conditions are used for ECM deposition, then cells can maintain normal growth and metabolism, but the amount of ECM deposited is insufficient and bioactivity is unstable
Solution Approach 1:
The patent applies macromolecular crowding (MMC) to fundamentally change the physical-chemical parameters of the cell culture environment. By introducing high concentrations of macromolecules (e.g., dextran, Ficoll, gelatin) to create crowded conditions, the patent enhances ECM deposition amount and stabilizes bioactivity. This parameter change transforms the culture environment from dilute to crowded, thereby resolving the contradiction between insufficient ECM deposition and unstable bioactivity.
Solution Approach 2:
The patent creates a composite system by combining cells with macromolecular crowders in a single culture medium. This composite approach allows the macromolecules to both crowd the cellular environment and serve as structural components of the ECM itself. The resulting composite ECM material exhibits enhanced deposition quantity and stabilized bioactivity, addressing the technical contradiction effectively.
2Ease of manufacture
If decellularization is performed to remove cells, then ECM can be used for therapeutic applications, but ECM bioactivity is decreased further
Solution Approach 1:
The patent performs preliminary ECM deposition under macromolecular crowding conditions before decellularization. By pre-establishing a robust ECM matrix with stabilized bioactivity during the cell-seeding phase, the subsequent decellularization process can remove cells while preserving the pre-formed, stable ECM structure. This preliminary action ensures that the ECM maintains its therapeutic bioactivity even after cell removal.
Solution Approach 2:
The patent changes the physical-chemical parameters of the ECM during deposition by applying MMC, creating a more stable and resilient ECM structure. This parameter change makes the ECM more resistant to degradation during decellularization, thereby preserving bioactivity. The crowded conditions during deposition create cross-linked and stabilized ECM structures that maintain their properties after cell removal.
3Productivity
If macromolecular crowding is applied to enhance ECM deposition, then ECM amount increases significantly, but the complexity of the culture system increases
Solution Approach 1:
The patent employs self-service principles by using macromolecules that simultaneously serve multiple functions: they create crowding conditions to enhance deposition, act as structural ECM components, and provide bioactivity stabilization. The macromolecules self-assemble with cellular secretions to form the ECM matrix without requiring additional complex processing steps. This multi-functionality increases productivity while minimizing the addition of complexity.
Solution Approach 2:
The patent applies universal macromolecules (such as dextran, Ficoll, or gelatin) that can serve multiple purposes in the culture system. These macromolecules function as crowders to enhance deposition, as structural ECM components, and as bioactivity stabilizers. This multi-functionality allows a single addition to the culture medium to address multiple needs, thereby increasing productivity without proportionally increasing system complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases ECM deposition and stability, enabling the generation of ECMs that can inhibit pro-inflammatory macrophage polarization and promote tissue healing and regeneration by modulating the microenvironment.
Implementation Method 1
Previously macromolecular crowding (MMC) has been used as a biophysical principle in in vitro biological systems... The successful application of this biophysical principle was demonstrated by accelerated enzyme kinetics, such as procollagen C protease, leading to enhanced collagen I deposition under MMC
Implementation Method 2
accelerated enzyme kinetics, such as procollagen C protease, leading to enhanced collagen I deposition under MMC
Implementation Method 3
It was also shown to increase supramolecular assemblies, ECM cross-linking and stabilization under MMC
Implementation Method 4
More recent findings have shown that for some macromolecules, such as dextran sulfate (DxS), the effect on ECM deposition was not due to the accelerated molecular kinetics related to the increased fractional volume occupancy of DxS, but rather to the co-aggregation and co-precipitation of the macromolecules with ECM components
Implementation Method 5
co-aggregation and co-precipitation of the macromolecules with ECM components
Implementation Method 6
A major limitation of in vitro extracellular matrices is thus their instable bioactivity, caused by too little amounts of ECM that are deposited under standard culture and decreased even further after decellularization
Data Source
AI summary
Provided are new methods for generating extracellular matrix material, compositions comprising the extracellular matrix material, and methods of using the extracellular matrix.